|
|
|
Volumn 3, Issue 3, 2002, Pages 437-440
|
|
Cannabis: Old medicine with new promise for neurological disorders
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 ARACHIDONOYLGLYCEROL;
2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE;
ACYLGLYCEROL;
ANANDAMIDE;
CANNABIDIOL;
CANNABINOID;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR;
CANNABINOID RECEPTOR ANTAGONIST;
CANNABINOL;
CANNABIS;
DRONABINOL;
MONOACYLGLYCEROL;
RIMONABANT;
ANALGESIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
ANTIOXIDANT ACTIVITY;
BIOSYNTHESIS;
BRAIN ISCHEMIA;
CELL MEMBRANE DEPOLARIZATION;
DEGENERATIVE DISEASE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG BRAIN LEVEL;
DRUG DOSAGE FORM;
DRUG PENETRATION;
DRUG POTENTIATION;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
GLIA CELL;
GROWTH REGULATION;
HUMAN;
IMMUNOMODULATION;
MICROGLIA;
MULTIPLE SCLEROSIS;
NERVOUS SYSTEM;
NEURITIS;
NEUROLOGIC DISEASE;
NEUROMODULATION;
NEUROPROTECTION;
NONHUMAN;
NOTE;
PHYTOCHEMISTRY;
RECEPTOR OCCUPANCY;
STROKE;
SYNAPTIC TRANSMISSION;
TARGET CELL;
TUMOR GROWTH;
ANIMALS;
CANNABINOIDS;
CANNABIS;
HUMANS;
NERVOUS SYSTEM DISEASES;
NEUROGLIA;
NEUROPROTECTIVE AGENTS;
PHYTOTHERAPY;
|
|
EID: 0036229970
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (18)
|
|
References (0)
|
